Harmony Biosciences Holdings, Inc. (HRMY) stock
HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)
Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –
Harmony Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
Harmony Biosciences's gross margin for the twelve months ending Jun 30, 2026 was 75.4%. For fiscal 2025 it was 77.2%, against 78.1% the year before. The highest annual figure on record is 82.6% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 77.2% | −0.9 |
| FY2024 | Dec 31, 2024 | 78.1% | −1.1 |
| FY2023 | Dec 31, 2023 | 79.2% | −1.8 |
| FY2022 | Dec 31, 2022 | 80.9% | −0.9 |
| FY2021 | Dec 31, 2021 | 81.8% | −0.8 |
| FY2020 | Dec 31, 2020 | 82.6% | +8.9 |
| FY2019 | Dec 31, 2019 | 73.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 75.8% | −5.2 |
| Q1 FY2026 | Mar 31, 2026 | 79.3% | −3.3 |
| Q4 FY2025 | Dec 31, 2025 | 71.9% | −1.1 |
| Q3 FY2025 | Sep 30, 2025 | 75.1% | −1.9 |
| Q2 FY2025 | Jun 30, 2025 | 81.0% | −0.4 |
| Q1 FY2025 | Mar 31, 2025 | 82.7% | +0.5 |
| Q4 FY2024 | Dec 31, 2024 | 73.0% | −1.4 |
| Q3 FY2024 | Sep 30, 2024 | 77.0% | −2.8 |
| Q2 FY2024 | Jun 30, 2024 | 81.4% | +0.0 |
| Q1 FY2024 | Mar 31, 2024 | 82.2% | −0.3 |
| Q4 FY2023 | Dec 31, 2023 | 74.4% | −4.7 |
| Q3 FY2023 | Sep 30, 2023 | 79.8% | −0.6 |
| Q2 FY2023 | Jun 30, 2023 | 81.4% | −1.0 |
| Q1 FY2023 | Mar 31, 2023 | 82.6% | −0.2 |
| Q4 FY2022 | Dec 31, 2022 | 79.0% | −1.4 |
| Q3 FY2022 | Sep 30, 2022 | 80.4% | −1.5 |
| Q2 FY2022 | Jun 30, 2022 | 82.3% | −0.5 |
| Q1 FY2022 | Mar 31, 2022 | 82.8% | +0.2 |
| Q4 FY2021 | Dec 31, 2021 | 80.5% | −1.9 |
| Q3 FY2021 | Sep 30, 2021 | 81.9% | −0.8 |
| Q2 FY2021 | Jun 30, 2021 | 82.8% | −0.2 |
| Q1 FY2021 | Mar 31, 2021 | 82.6% | +0.1 |
| Q4 FY2020 | Dec 31, 2020 | 82.4% | – |
| Q3 FY2020 | Sep 30, 2020 | 82.7% | – |
| Q2 FY2020 | Jun 30, 2020 | 83.0% | – |
| Q1 FY2020 | Mar 31, 2020 | 82.5% | – |
See a number that looks wrong?